World Top 100 Biotechnology Companies List by Market Cap as of August 2026

World Top 100 Biotechnology Companies List by Market Cap as of August 2026, World Biggest 100 Biotechnology Companies by Market Cap, World Largest 100 Biotechnology Companies in the World by market cap as of August 2026.

World Top Biotechnology Companies in 2026
World Largest Biotechnology Companies by Market Cap in 2026, World Top Biotechnology Companies by Market Cap in 2026.

  1. Jiangsu Wuzhong Industrial Co. Ltd

    World Rank (Aug-2026)
    6,775
    Market Cap (Aug-2026)
    1.785 Billion USD
    World Rank (Jan-05-2024)
    9,028
    Market Cap (Jan-05-2024)
    0.920 Billion USD
    World Rank (Jul-30-2023)
    10,127
    Market Cap (Jul-30-2023)
    0.770 Billion USD
    World Rank (Dec-25-2022)
    10,100
    Market Cap (Dec-25-2022)
    0.732 Billion USD
    World Rank (Jan-07-2022)
    10,213
    Market Cap (Jan-07-2022)
    0.87 Billion USD
    Headquarters Country
    China
    Yahoo @ Shanghai
    Company Website
    JIANGSU WUZHONG INDUSTRIAL CO. LTD

  2. Zymeworks

    World Rank (Aug-2026)
    6,788
    Market Cap (Aug-2026)
    1.782 Billion USD
    World Rank (Jan-05-2024)
    10,077
    Market Cap (Jan-05-2024)
    0.758 Billion USD
    World Rank (Jul-30-2023)
    13,171
    Market Cap (Jul-30-2023)
    0.467 Billion USD
    World Rank (Dec-25-2022)
    12,463
    Market Cap (Dec-25-2022)
    0.496 Billion USD
    World Rank (Jan-07-2022)
    11,722
    Market Cap (Jan-07-2022)
    0.66 Billion USD
    Annual Revenue in USD
    20 Million USD
    Annual Net Income in USD
    -162 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Canada
    Yahoo @ NYSE
    Company Profile
    Zymeworks is a clinical Stage Biotechnology company. The company dedicated to the discovery, development, and commercialization of next generation multifunctional biotherapeutics initially focused on the treatment of cancer. The headquarters is in Canada.
    Company Website
    ZYMEWORKS INC

  3. Syndax Pharmaceuticals

    World Rank (Aug-2026)
    6,806
    Market Cap (Aug-2026)
    1.772 Billion USD
    World Rank (Jan-05-2024)
    6,088
    Market Cap (Jan-05-2024)
    1.788 Billion USD
    World Rank (Jul-30-2023)
    6,989
    Market Cap (Jul-30-2023)
    1.461 Billion USD
    World Rank (Dec-25-2022)
    6,132
    Market Cap (Dec-25-2022)
    1.655 Billion USD
    World Rank (Jan-07-2022)
    9,280
    Market Cap (Jan-07-2022)
    1.03 Billion USD
    Annual Revenue in USD
    172 Million USD
    Annual Operating Income in USD
    -273 Million USD
    Annual Net Income in USD
    -285 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Syndax Pharmaceuticals is a Clinical Stage Biopharmaceutical company developing an innovative pipeline of cancer therapies. The company annual revenue is 1.5 million USD and 38 employees as on 2019. The headquarters is in USA.
    Company Website
    SYNDAX PHARMACEUTICALS

  4. Porton Pharma Solutions

    World Rank (Aug-2026)
    6,819
    Market Cap (Aug-2026)
    1.766 Billion USD
    World Rank (Jan-05-2024)
    5,987
    Market Cap (Jan-05-2024)
    1.840 Billion USD
    World Rank (Jul-30-2023)
    5,451
    Market Cap (Jul-30-2023)
    2.176 Billion USD
    World Rank (Dec-25-2022)
    4,070
    Market Cap (Dec-25-2022)
    3.007 Billion USD
    World Rank (Jan-07-2022)
    2,779
    Market Cap (Jan-07-2022)
    6.16 Billion USD
    Annual Revenue in USD
    487 Million USD
    Annual Net Income in USD
    82 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    China
    Yahoo @ Shenzhen
    Company Website
    PORTON PHARMA SOLUTIONS

  5. Xencor

    World Rank (Aug-2026)
    6,884
    Market Cap (Aug-2026)
    1.735 Billion USD
    World Rank (Jan-05-2024)
    7,236
    Market Cap (Jan-05-2024)
    1.346 Billion USD
    World Rank (Jul-30-2023)
    7,028
    Market Cap (Jul-30-2023)
    1.449 Billion USD
    World Rank (Dec-25-2022)
    6,390
    Market Cap (Dec-25-2022)
    1.564 Billion USD
    World Rank (Jan-07-2022)
    5,875
    Market Cap (Jan-07-2022)
    2.22 Billion USD
    Annual Revenue in USD
    126 Million USD
    Annual Operating Income in USD
    -178 Million USD
    Annual Net Income in USD
    -92 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Xencor is a Clinical Stage Biopharmaceutical company. It has portfolio of 18 proprietary and partnered therapeutic antibody and cytokine programs in clinical development for the treatment of cancer autoimmune disorders and infectious disease. The headquarters is in USA.
    Facts About Company
    As on 2021, Xencor had 254 full-time employees.
    Company Website
    XENCOR INC

  6. AnaptysBio Inc.

    World Rank (Aug-2026)
    6,897
    Market Cap (Aug-2026)
    1.731 Billion USD
    World Rank (Jan-05-2024)
    11,751
    Market Cap (Jan-05-2024)
    0.575 Billion USD
    World Rank (Jul-30-2023)
    13,367
    Market Cap (Jul-30-2023)
    0.453 Billion USD
    World Rank (Dec-25-2022)
    9,383
    Market Cap (Dec-25-2022)
    0.831 Billion USD
    World Rank (Jan-07-2022)
    9,972
    Market Cap (Jan-07-2022)
    0.91 Billion USD
    Annual Revenue in USD
    235 Million USD
    Annual Operating Income in USD
    48 Million USD
    Annual Net Income in USD
    -13 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    AnaptysBio is a Clinical Stage Biotechnology company developing first in class immunology therapeutic product candidates to patients. The company annual revenue is 75 million USD and 89 employees as on 2020. The headquarters is in USA.
    Company Website
    ANAPTYSBIO INC

  7. Biotest

    World Rank (Aug-2026)
    6,900
    Market Cap (Aug-2026)
    1.729 Billion USD
    World Rank (Jan-05-2024)
    6,541
    Market Cap (Jan-05-2024)
    1.590 Billion USD
    World Rank (Jul-30-2023)
    6,536
    Market Cap (Jul-30-2023)
    1.623 Billion USD
    World Rank (Dec-25-2022)
    6,266
    Market Cap (Dec-25-2022)
    1.607 Billion USD
    World Rank (Jan-07-2022)
    6,569
    Market Cap (Jan-07-2022)
    1.87 Billion USD
    Annual Revenue in USD
    569 Million USD
    Annual Operating Income in USD
    -9 Million USD
    Annual Net Income in USD
    -35 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Germany
    Yahoo @ Germany
    Company Profile
    Biotest is a specialist in innovative haematology, clinical immunology and intensive care medicine company develops, manufactures and markets plasma proteins and biotherapeutic drugs. It is having more than 1,900 employees. The company annual revenue is 484.2 million EUR and total assets are 1,131.3 million EUR as on 2020. The headquarters is in Germany.
    Company Website
    BIOTEST

  8. BioLife Solutions Inc.

    World Rank (Aug-2026)
    6,929
    Market Cap (Aug-2026)
    1.715 Billion USD
    World Rank (Jan-05-2024)
    10,505
    Market Cap (Jan-05-2024)
    0.707 Billion USD
    World Rank (Jul-30-2023)
    9,534
    Market Cap (Jul-30-2023)
    0.858 Billion USD
    World Rank (Dec-25-2022)
    9,928
    Market Cap (Dec-25-2022)
    0.755 Billion USD
    World Rank (Jan-07-2022)
    8,152
    Market Cap (Jan-07-2022)
    1.28 Billion USD
    Annual Revenue in USD
    96 Million USD
    Annual Operating Income in USD
    -17 Million USD
    Annual Net Income in USD
    -5 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    BioLife Solutions is a supplier of class defining cell and Gene Therapy Bioproduction tools and services company. The headquarters is in USA.
    Facts About Company
    BioLife Solutions company annual revenue was 161 million USD and annual net loss was -139 as on 2019.
    Company Website
    BIOLIFE SOLUTIONS

  9. Syngene International

    World Rank (Aug-2026)
    6,976
    Market Cap (Aug-2026)
    1.694 Billion USD
    World Rank (Jan-05-2024)
    3,883
    Market Cap (Jan-05-2024)
    3.503 Billion USD
    World Rank (Jul-30-2023)
    3,508
    Market Cap (Jul-30-2023)
    4.030 Billion USD
    World Rank (Dec-25-2022)
    4,331
    Market Cap (Dec-25-2022)
    2.788 Billion USD
    World Rank (Jan-07-2022)
    4,440
    Market Cap (Jan-07-2022)
    3.39 Billion USD
    Annual Revenue in USD
    388 Million USD
    Annual Operating Income in USD
    74 Million USD
    Annual Net Income in USD
    56 Million USD
    Annual Results for Period Ending
    Mar-2023 ending year
    Headquarters Country
    India
    Stock Category
    S&P BSE HEALTH CARE
    Yahoo @ BSE
    Company Profile
    Syngene International is an integrated research, development and manufacturing organisation providing scientific services company. It is offering services in a wide range of industrial sectors, including pharmaceutical, biotechnology, nutrition, animal health, consumer goods and speciality chemical companies. The company annual revenue is 255.4 million USD and 6,148 employees as on 2020. The headquarters is in India.
    Company Website
    Syngene International

  10. Recursion Pharmaceuticals Inc.

    World Rank (Aug-2026)
    6,978
    Market Cap (Aug-2026)
    1.692 Billion USD
    World Rank (Jan-05-2024)
    5,212
    Market Cap (Jan-05-2024)
    2.314 Billion USD
    World Rank (Jul-30-2023)
    4,907
    Market Cap (Jul-30-2023)
    2.524 Billion USD
    World Rank (Dec-25-2022)
    6,761
    Market Cap (Dec-25-2022)
    1.424 Billion USD
    World Rank (Jan-07-2022)
    5,259
    Market Cap (Jan-07-2022)
    2.67 Billion USD
    Annual Revenue in USD
    75 Million USD
    Annual Operating Income in USD
    -648 Million USD
    Annual Net Income in USD
    -645 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Recursion Pharmaceuticals, Inc. is a clinical stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning and engineering to industrialize drug discovery. The company annual revenue is 10 million USD and net loss of 186 Million USD as on 2021. The headquarters is in USA.
    Company Website
    RECURSION PHARMACEUTICALS, INC.

Share